Clinical Trial Update: Effect of Combined Incretin-Based Therapy Plus Canagliflozin on Glycemic Control and the Compensatory Rise in Hepatic Glucose Production in Type 2 Diabetic Patients [NA]

View source ↗

Summary

A completed clinical trial evaluating the combination of incretin-based therapy with canagliflozin for glycemic control in type 2 diabetes and its effect on hep…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• Canagliflozin (canagliflozin)
• Incretin-based therapy

Snippet

Sponsor: The University of Texas Health Science Center at San Antonio | Conditions: Type 2 Diabetes Mellitus | NA | Status: COMPLETED | Results posted: 2019-05-14